Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District [Phase 2]
Phase 2 trial update on accelerated modulated fractionation (SIB-IMRT) for head and neck carcinoma.
-
FDA approval · 2023-06-16FDA Approved: CARBOPLATIN — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for generic carboplatin. This action permits Apotex to market a generic carboplatin for…
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer [Phase 1]
Phase 1 clinical trial evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab imaging agents for identifying metastatic lymph nodes in patient…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137) [Phase 1]
A Phase 1 trial evaluating talimogene laherparepvec in combination with pembrolizumab for recurrent metastatic squamous cell carcinoma of th…